Fresenius SE & Co. (OTCMKTS:FSNUY) Hits New 1-Year Low – What’s Next?

Posted by Chris Copeland on May 5th, 2026

Fresenius SE & Co. (OTCMKTS:FSNUY – Get Free Report)’s share price reached a new 52-week low on Tuesday . The stock traded as low as $11.54 and last traded at $11.54, with a volume of 25412 shares changing hands. The stock had previously closed at $11.98.

Analyst Ratings Changes

FSNUY has been the subject of several research reports. Morgan Stanley restated an “overweight” rating on shares of Fresenius SE & Co. in a research note on Monday, April 20th. Citigroup restated a “buy” rating on shares of Fresenius SE & Co. in a research note on Tuesday, February 3rd. Three research analysts have rated the stock with a Buy rating, Based on data from MarketBeat, the stock presently has a consensus rating of “Buy”.

View Our Latest Stock Report on FSNUY

Fresenius SE & Co. Trading Down 2.9%

The firm has a market capitalization of $26.20 billion, a PE ratio of 18.46 and a beta of 0.68. The company’s 50-day moving average price is $13.27 and its 200-day moving average price is $14.19. The company has a debt-to-equity ratio of 0.47, a quick ratio of 1.00 and a current ratio of 1.32.

Fresenius SE & Co. (OTCMKTS:FSNUY – Get Free Report) last released its quarterly earnings data on Wednesday, February 25th. The company reported $0.28 earnings per share (EPS) for the quarter. The business had revenue of $6.94 billion during the quarter. Fresenius SE & Co. had a net margin of 5.71% and a return on equity of 10.31%. On average, sell-side analysts expect that Fresenius SE & Co. will post 1.05 earnings per share for the current year.

About Fresenius SE & Co.

(Get Free Report)

Fresenius SE & Co KGaA is a global healthcare group headquartered in Bad Homburg vor der Höhe, Germany. Founded in 1912 by Eduard Fresenius, the company has grown into one of the world’s leading providers of products and services for dialysis, hospitals and outpatient medical care. Trading on major European exchanges and available over the counter in the U.S. as FSNUY, Fresenius SE & Co brings together a portfolio of specialized healthcare businesses under one corporate umbrella.

The company operates through four main business segments.